JP Stock MarketDetailed Quotes

4570 Immuno-Biological Laboratories

Watchlist

493
-3-0.60%

20min DelayMarket Closed Nov 29 15:30 JST

4.59BMarket Cap24.59P/E (Static)

Immuno-Biological Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

2.78%816.7M

11.92%268.3M

-30.13%182.89M

37.76%188.33M

13.25%177.19M

22.71%794.62M

20.16%239.71M

34.86%261.74M

6.11%136.71M

25.01%156.46M

Cost of revenue

11.76%299.41M

0.55%77.54M

0.39%71.11M

27.34%76.37M

24.00%74.39M

-1.10%267.91M

9.72%77.11M

-0.79%70.83M

-13.98%59.98M

0.86%59.99M

Gross profit

-1.79%517.29M

17.32%190.76M

-41.45%111.78M

45.90%111.95M

6.57%102.8M

39.82%526.71M

25.84%162.6M

55.60%190.92M

29.80%76.73M

46.89%96.47M

Operating expense

-12.05%412.99M

-21.81%97.22M

-2.68%114.32M

-14.78%99.23M

-8.17%102.22M

-5.88%469.56M

8.35%124.33M

-4.39%117.47M

-4.36%116.44M

-20.24%111.32M

Staff costs

0.28%177.85M

----

-10.25%177.36M

----

Selling and administrative expenses

-15.13%7.42M

----

83.66%8.75M

----

-General and administrative expense

-15.13%7.42M

----

83.66%8.75M

----

Research and development costs

-27.85%129.98M

----

-4.47%180.15M

----

Depreciation and amortization

--1.97M

----

--0

----

-Depreciation

--1.97M

----

--0

----

Other operating expenses

-7.30%95.76M

----

-4.30%103.3M

----

Operating profit

82.49%104.3M

144.45%93.54M

-103.46%-2.54M

132.04%12.72M

103.88%577K

146.77%57.15M

164.58%38.27M

46,883.44%73.45M

36.60%-39.7M

79.89%-14.86M

Net non-operating interest income (expenses)

-466.43%-1.04M

-326.53%-222K

-461.54%-329K

-378.82%-237K

-2,866.67%-249K

283.77%283K

1,125.00%98K

195.79%91K

365.63%85K

125.71%9K

Non-operating interest income

-93.14%93K

-78.08%80K

-109.42%-34K

-91.57%30K

-93.80%17K

178.44%1.36M

34.69%365K

139.07%361K

493.33%356K

5,380.00%274K

Non-operating interest expense

5.31%1.13M

13.11%302K

9.26%295K

-1.48%267K

0.38%266K

67.39%1.07M

1.52%267K

9.76%270K

194.57%271K

562.50%265K

Net investment income

90.88%8.7M

200.50%3.59M

42.75%-3.19M

-27.93%2.36M

4.89%5.94M

51.71%4.56M

-42.56%1.2M

-684.28%-5.57M

1,037.50%3.28M

1,874.61%5.66M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

99.91%-166K

85.02%-166K

-176.1M

-175M

-1.11M

Income from associates and other participating interests

-33.46%-203.84M

-119.56%-107.29M

86.72%-6.2M

-65.56%-41.16M

-52.23%-49.2M

Special income (charges)

-85.29%6.34M

252.17%162K

89.81%6.18M

162.71%43.12M

126.10%39.1M

-98.49%46K

713K

182.79%3.26M

Less:Other special charges

99.51%-249K

--0

-252.17%-162K

--0

97.86%-87K

-115.82%-50.62M

-164.83%-45.8M

98.49%-46K

---713K

-30.70%-4.06M

Less:Write off

-181.26%-6.1M

--0

-858.08%-6.1M

6.53%7.5M

--6.7M

--0

-88.58%804K

Other non-operating income (expenses)

212.61%6.5M

136.46%2.71M

384.33%1.05M

22.68%2.27M

215.02%467K

-204.11%-5.77M

-425.43%-7.44M

-70.60%217K

163.07%1.85M

-122.33%-406K

Income before tax

144.42%124.64M

147.20%99.62M

-107.82%-4.85M

122.85%17.12M

122.50%12.75M

-12.18%-280.61M

-1,556.93%-211.06M

247.01%62.03M

13.40%-74.94M

47.88%-56.64M

Income tax

-780.45%-62.05M

-3,067.90%-66.48M

-37.90%1.42M

-37.88%1.43M

-30.98%1.58M

5.73%9.12M

-10.93%2.24M

15.28%2.29M

11.20%2.29M

11.37%2.29M

Net income

164.44%186.69M

177.87%166.11M

-110.50%-6.27M

120.32%15.7M

118.94%11.17M

-11.97%-289.73M

-1,298.51%-213.3M

235.21%59.74M

12.82%-77.23M

46.78%-58.94M

Net income continuous operations

164.44%186.69M

177.87%166.11M

-110.50%-6.27M

120.32%15.7M

118.94%11.17M

-11.97%-289.73M

-1,298.41%-213.3M

235.21%59.74M

12.82%-77.23M

46.78%-58.94M

Noncontrolling interests

Net income attributable to the company

164.44%186.69M

177.87%166.11M

-110.50%-6.27M

120.32%15.7M

118.94%11.17M

-11.97%-289.73M

-1,298.51%-213.3M

235.21%59.74M

12.82%-77.23M

46.78%-58.94M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

164.44%186.69M

177.87%166.11M

-110.50%-6.27M

120.32%15.7M

118.94%11.17M

-11.97%-289.73M

-1,298.51%-213.3M

235.21%59.74M

12.82%-77.23M

46.78%-58.94M

Gross dividend payment

Basic earnings per share

164.47%20.05

177.90%17.84

-110.44%-0.67

120.36%1.69

118.83%1.19

-11.95%-31.1

-1,296.34%-22.9

235.44%6.42

12.72%-8.3

46.85%-6.32

Diluted earnings per share

164.47%20.05

177.87%17.8351

-110.50%-0.6735

120.30%1.6853

118.83%1.19

-11.95%-31.1

-1,296.49%-22.9024

235.21%6.4142

12.75%-8.3

46.85%-6.32

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	2.78%816.7M	11.92%268.3M	-30.13%182.89M	37.76%188.33M	13.25%177.19M	22.71%794.62M	20.16%239.71M	34.86%261.74M	6.11%136.71M	25.01%156.46M
Cost of revenue	11.76%299.41M	0.55%77.54M	0.39%71.11M	27.34%76.37M	24.00%74.39M	-1.10%267.91M	9.72%77.11M	-0.79%70.83M	-13.98%59.98M	0.86%59.99M
Gross profit	-1.79%517.29M	17.32%190.76M	-41.45%111.78M	45.90%111.95M	6.57%102.8M	39.82%526.71M	25.84%162.6M	55.60%190.92M	29.80%76.73M	46.89%96.47M
Operating expense	-12.05%412.99M	-21.81%97.22M	-2.68%114.32M	-14.78%99.23M	-8.17%102.22M	-5.88%469.56M	8.35%124.33M	-4.39%117.47M	-4.36%116.44M	-20.24%111.32M
Staff costs	0.28%177.85M	----	----	----	----	-10.25%177.36M	----	----	----	----
Selling and administrative expenses	-15.13%7.42M	----	----	----	----	83.66%8.75M	----	----	----	----
-General and administrative expense	-15.13%7.42M	----	----	----	----	83.66%8.75M	----	----	----	----
Research and development costs	-27.85%129.98M	----	----	----	----	-4.47%180.15M	----	----	----	----
Depreciation and amortization	--1.97M	----	----	----	----	--0	----	----	----	----
-Depreciation	--1.97M	----	----	----	----	--0	----	----	----	----
Other operating expenses	-7.30%95.76M	----	----	----	----	-4.30%103.3M	----	----	----	----
Operating profit	82.49%104.3M	144.45%93.54M	-103.46%-2.54M	132.04%12.72M	103.88%577K	146.77%57.15M	164.58%38.27M	46,883.44%73.45M	36.60%-39.7M	79.89%-14.86M
Net non-operating interest income (expenses)	-466.43%-1.04M	-326.53%-222K	-461.54%-329K	-378.82%-237K	-2,866.67%-249K	283.77%283K	1,125.00%98K	195.79%91K	365.63%85K	125.71%9K
Non-operating interest income	-93.14%93K	-78.08%80K	-109.42%-34K	-91.57%30K	-93.80%17K	178.44%1.36M	34.69%365K	139.07%361K	493.33%356K	5,380.00%274K
Non-operating interest expense	5.31%1.13M	13.11%302K	9.26%295K	-1.48%267K	0.38%266K	67.39%1.07M	1.52%267K	9.76%270K	194.57%271K	562.50%265K
Net investment income	90.88%8.7M	200.50%3.59M	42.75%-3.19M	-27.93%2.36M	4.89%5.94M	51.71%4.56M	-42.56%1.2M	-684.28%-5.57M	1,037.50%3.28M	1,874.61%5.66M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	99.91%-166K	0	0	0	85.02%-166K	-176.1M	-175M	0	0	-1.11M
Income from associates and other participating interests	0	0			0	-33.46%-203.84M	-119.56%-107.29M	86.72%-6.2M	-65.56%-41.16M	-52.23%-49.2M
Special income (charges)	-85.29%6.34M	0	252.17%162K	0	89.81%6.18M	162.71%43.12M	126.10%39.1M	-98.49%46K	713K	182.79%3.26M
Less:Other special charges	99.51%-249K	--0	-252.17%-162K	--0	97.86%-87K	-115.82%-50.62M	-164.83%-45.8M	98.49%-46K	---713K	-30.70%-4.06M
Less:Write off	-181.26%-6.1M	--0	--0	--0	-858.08%-6.1M	6.53%7.5M	--6.7M	--0	--0	-88.58%804K
Other non-operating income (expenses)	212.61%6.5M	136.46%2.71M	384.33%1.05M	22.68%2.27M	215.02%467K	-204.11%-5.77M	-425.43%-7.44M	-70.60%217K	163.07%1.85M	-122.33%-406K
Income before tax	144.42%124.64M	147.20%99.62M	-107.82%-4.85M	122.85%17.12M	122.50%12.75M	-12.18%-280.61M	-1,556.93%-211.06M	247.01%62.03M	13.40%-74.94M	47.88%-56.64M
Income tax	-780.45%-62.05M	-3,067.90%-66.48M	-37.90%1.42M	-37.88%1.43M	-30.98%1.58M	5.73%9.12M	-10.93%2.24M	15.28%2.29M	11.20%2.29M	11.37%2.29M
Net income	164.44%186.69M	177.87%166.11M	-110.50%-6.27M	120.32%15.7M	118.94%11.17M	-11.97%-289.73M	-1,298.51%-213.3M	235.21%59.74M	12.82%-77.23M	46.78%-58.94M
Net income continuous operations	164.44%186.69M	177.87%166.11M	-110.50%-6.27M	120.32%15.7M	118.94%11.17M	-11.97%-289.73M	-1,298.41%-213.3M	235.21%59.74M	12.82%-77.23M	46.78%-58.94M
Noncontrolling interests
Net income attributable to the company	164.44%186.69M	177.87%166.11M	-110.50%-6.27M	120.32%15.7M	118.94%11.17M	-11.97%-289.73M	-1,298.51%-213.3M	235.21%59.74M	12.82%-77.23M	46.78%-58.94M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	164.44%186.69M	177.87%166.11M	-110.50%-6.27M	120.32%15.7M	118.94%11.17M	-11.97%-289.73M	-1,298.51%-213.3M	235.21%59.74M	12.82%-77.23M	46.78%-58.94M
Gross dividend payment
Basic earnings per share	164.47%20.05	177.90%17.84	-110.44%-0.67	120.36%1.69	118.83%1.19	-11.95%-31.1	-1,296.34%-22.9	235.44%6.42	12.72%-8.3	46.85%-6.32
Diluted earnings per share	164.47%20.05	177.87%17.8351	-110.50%-0.6735	120.30%1.6853	118.83%1.19	-11.95%-31.1	-1,296.49%-22.9024	235.21%6.4142	12.75%-8.3	46.85%-6.32
Dividend per share	0	0	0	0	0	0	0	0	0	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data